VC
Vivo Capital’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.06M | Hold |
1,122,471
| – | – | 0.82% | 27 |
|
|
2025
Q1 | $6.72M | Hold |
1,122,471
| – | – | 0.89% | 26 |
|
|
2024
Q4 | $8.76M | Hold |
1,122,471
| – | – | 0.98% | 24 |
|
|
2024
Q3 | $12.1M | Sell |
1,122,471
-1,122,470
| -50% | -$12.1M | 1% | 20 |
|
|
2024
Q2 | $18.9M | Hold |
2,244,941
| – | – | 1.75% | 14 |
|
|
2024
Q1 | $15.1M | Hold |
2,244,941
| – | – | 1.19% | 19 |
|
|
2023
Q4 | $13.2M | Hold |
2,244,941
| – | – | 1.08% | 18 |
|
|
2023
Q3 | $21.9M | Hold |
2,244,941
| – | – | 2.4% | 13 |
|
|
2023
Q2 | $26.6M | Buy |
2,244,941
+250,000
| +13% | +$2.96M | 1.83% | 12 |
|
|
2023
Q1 | $21.5M | Hold |
1,994,941
| – | – | 1.49% | 12 |
|
|
2022
Q4 | $23.1M | Buy |
1,994,941
+111,000
| +6% | +$1.28M | 2.66% | 13 |
|
|
2022
Q3 | $28.1M | Sell |
1,883,941
-37,000
| -2% | -$552K | 3.1% | 11 |
|
|
2022
Q2 | $17.3M | Hold |
1,920,941
| – | – | 1.74% | 12 |
|
|
2022
Q1 | $14.4M | Hold |
1,920,941
| – | – | 0.99% | 23 |
|
|
2021
Q4 | $16.5M | Buy |
1,920,941
+500,000
| +35% | +$4.29M | 0.99% | 25 |
|
|
2021
Q3 | $12M | Buy |
+1,420,941
| New | +$12M | 0.54% | 33 |
|